Qsymia (phentermine/topiramate)

Qsymia is a prescription chronic weight management medication that contains two phentermine/topiramate extended-release. The medication was approved by the U.S. Food and Drug Administration (FDA) in 2012 for use in obese adults and some overweight adults who are struggling to lose weight. The medication is designed to be used in conjunction with a physician-approved diet, physical activity, and behavioral changes plan in order to help patients lose weight and keep it off.Qsymia is the most effective weight loss drug available to date. It combines an adrenergic agonist with a neurostabilizer. Adults with migraines and obesity are good candidates for this weight loss medication Get your copy today by scrolling up and clicking Buy Now to get your copy today It's no secret that obesity is an epidemic in the United States, with approximately 42.2 percent of American adults classified as obese according to the Centers for Disease Prevention and Control.